Skip to content
lifestyle.travelshq.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
BriaCell Therapeutics Corp.
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
October 23, 2026
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
October 6, 2026
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
September 14, 2026
BriaCell Phase 3 Metastatic Breast Cancer Trial Expands to MSK
September 8, 2026
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
August 24, 2026
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
August 5, 2026
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
May 15, 2026
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
May 14, 2026
BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 13, 2026
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
May 12, 2026
1
2
Next Page
→